The abnormal conditions to which blood is subjected during cardiopulmonary bypass (CPB) trigger an activation of the inflammatory response and cause pulmonary dysfunction. It has been suggested that high-volume, zero-balanced ultrafiltration (ZBUF) facilitates clearance of inflammatory mediators and improves post-operative pulmonary function. Procalcitonin, a newly discovered inflammatory mediator, has been found to be increased after CPB and has been proven to be an appropriate parameter for predicting pulmonary dysfunction secondary to CPB. The aim of this study was to investigate the effects of zero-balanced ultrafiltration (ZBUF) on procalcitonin (PCT) and respiratory function of infants with Tetralogy of Fallot (TOF) after CPB. Twenty infants with TOF undergoing open-heart total surgical correction were randomly assigned to two groups. The trial group was given ZBUF (50 ml/kg) and conventional ultrafiltration (CUF), while the control group was given CUF only. Plasma PCT and pulmonary function were monitored and compared between the two groups before the operation (T1), before rewarming (T2), at the end of the operation (T3), and at 12 h, 24 h and 48 h after the operation (T4-T6). PCT was decreased in the trial group between 12 h and 48 h post-operatively, but the differences did not reach statistical significance. The trial group's pulmonary compliance was higher at 12 h post-operatively (p < 0.05). Oxygenation index was increased in the trial group at the end of the operation and 12 h post-operatively (p > 0.05). Intubation time was shorter in the trial group (P < 0.01). A positive correlation was found between peak PCT concentration and intubation time. ZBUF appeared to improve ventilation and shorten intubation time. The improved respiratory function may be due to the lower plasma PCT.Perfusion (2007) 22, 339—343.
Get full access to this article
View all access options for this article.
References
1.
Wan S. , LeClerc JL , Vincent JLInflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies . Chest1997; 112(3): 676—87.
2.
Journois D. , Israel-Biet D. , Pouard P. , et al. High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children . Anesthesiology1996; 85: 965—76.
3.
Huang H. , Yao T. , Wang W. , et al. Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass . Ann Thorac Surg2003; Jul, 76(1): 136—40.
4.
Darling E. , Searles B. , Nasrallah F. , et al. High-volume, zero-balanced ultrafiltration improves pulmonary function in a model of post-pump syndrome . JECT2002; 34: 254—59.
5.
Hensel M. , Volk T. , Döcke WD , et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass [Clinical Investigations] . Anesthesiology1998 Jul; 89(1): 93—104.
6.
Level C. , Chauveau P. , Guisset O.Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure . Crit Care2003 Dec; 7(6): R160—66.
7.
Tallman RD , Dumond M. , Brown D.Inflammatory mediator removal by zero-balance ultrafiltration during cardiopulmonary bypass . Perfusion2002 Mar; 17(2): 111—15.
8.
Chew MS , Brix-Christensen V. , Ravn HB , et al. Effect of modified ultrafiltration on the inflammatory response in paediatric open-heart surgery: a prospective, randomized study . Perfusion, 2002 Sep; 17(5): 327—33.
9.
Whang KT , Vath SD , Becker KL , et al. Procalcitonin and proinflammatory cytokine interactions in sepsis . Shock2000 Jul; 14(1): 73—8.
10.
Michalik DE , Duncan BW , Mee RB , et al. Quantitative analysis of procalcitonin after pediatric cardiothoracic surgery . Cardiol Young2006 Feb; 16(1): 48—53.
